A craniotomy is a skull opening in which the removed bone flap is replaced before the incision is closed; a craniectomy is the same opening without replacement, leaving the brain temporarily uncovered by bone. The choice depends on whether the brain is expected to swell enough that a closed skull would become dangerous. Craniotomy is the default for most elective brain operations; craniectomy is reserved mainly for trauma, stroke, and infection, and it commits the patient to a second operation.
The bone-flap decision, mechanism by mechanism
The skull is a closed box. Once the dura is opened, the brain has nowhere to expand except through the opening. Whether the surgeon gives the bone back at the end of the case is therefore a decision about the physics of that box, not about the skin incision.
In a craniotomy, the surgeon cuts a bone flap with a high-speed drill, lifts it, performs the intradural work, then fixes it back with titanium plates and screws before closing the scalp. The replaced flap restores the skull's contour, protects the brain, and lets the scalp heal over a rigid surface. Because the bone is present at closure, any postoperative swelling must be absorbed by the reserved intracranial space or managed medically.
In a craniectomy, the same flap is removed but not replaced. The dura is usually left open or patched, and the scalp is closed over the brain. The decompression is mechanical: the brain can herniate outward through the defect rather than downward through the tentorial opening or across the midline. That is the physiologic rationale for a decompressive craniectomy in raised intracranial pressure. The cost is a second operation, typically weeks to months later, to reconstruct the skull (cranioplasty).
The distinction matters because the two procedures carry different risk profiles, different follow-up obligations, and different consent conversations. A patient consented for "craniotomy" who wakes up without a bone flap has undergone a different operation with a different recovery arc.
Quantified context: when the numbers point one way
The clearest evidence for decompressive craniectomy comes from malignant middle cerebral artery infarction and from severe traumatic brain injury with refractory intracranial hypertension. In hemispheric stroke, decompressive surgery within 48 hours of symptom onset reduces mortality and improves functional outcomes in selected patients, and major society guidance treats it as a life-saving option for malignant edema. The threshold language in practice is intracranial pressure sustained above roughly 20–22 mmHg despite tiered medical therapy, though the exact trigger is individualized.
In traumatic brain injury, the picture is more nuanced. The RESCUEicp trial (Hutchinson et al., New England Journal of Medicine, 2016) randomized patients with refractory intracranial hypertension to decompressive craniectomy versus continued medical management and found lower mortality with surgery but higher rates of vegetative state and severe disability. The DECRA trial (Cooper et al., New England Journal of Medicine, 2011) found that early decompressive craniectomy for diffuse swelling did not improve outcomes and was associated with more unfavorable results than medical management. The professional caveat is that decompressive craniectomy is a rescue therapy, not a routine escalation; it trades mortality for survival with disability in a substantial fraction of patients.
For cranioplasty timing, the literature does not converge on a single window. Early replacement (often within weeks) may reduce complications related to the sinking skin flap syndrome, while delayed replacement lowers infection risk in some series. The practical point is that the second operation is not optional and its timing is a genuine clinical decision, not an afterthought.
Comparison at a glance
| Feature | Craniotomy | Craniectomy |
|---|---|---|
| Bone flap at closure | Replaced and fixed | Removed, not replaced |
| Primary indication | Elective tumor, aneurysm, epilepsy, biopsy | Refractory intracranial hypertension, trauma, stroke, infection |
| Skull defect after surgery | None | Present until cranioplasty |
| Second operation | Not routine | Required (cranioplasty) |
| Cosmetic outcome | Normal contour | Contour defect until reconstruction |
| Brain protection | Rigid skull restored | Brain unprotected at defect |
| Typical follow-up burden | Standard postoperative | Wound surveillance plus cranioplasty planning |
Timeline: what happens after each
| Phase | Craniotomy | Craniectomy |
|---|---|---|
| Immediate postoperative | Bone flap fixed, scalp closed | Defect present, scalp closed over brain |
| First 24–48 hours | ICU monitoring for hematoma and edema | ICU monitoring, often with intracranial pressure monitoring |
| First week | Wound check, imaging | Wound check, imaging, positioning precautions |
| Weeks 1–6 | Gradual mobilization | Head protection counseling, helmet often advised |
| Months 1–3 | Return to baseline activity as tolerated | Cranioplasty planning begins |
| Cranioplasty window | Not applicable | Typically weeks to months, individualized |
| Long-term | Skull intact | Skull reconstructed; contour restored |
Edge cases and the counterintuitive detail
The counterintuitive point is that a craniectomy is not simply "a craniotomy without the bone back." The dura is often left open or patched, which changes the wound's biology and the infection risk. The bone flap itself is typically stored in a tissue bank or, in some settings, in the abdominal subcutaneous tissue, and storage method affects later infection and resorption rates.
Edge cases where the decision is genuinely difficult include:
A patient with a large tumor and expected postoperative edema, where the surgeon may plan a craniectomy upfront rather than risk a second operation under worse conditions. A decompressive craniectomy performed emergently at night, where the bone flap may be stored rather than discarded, preserving the option of replacement. A craniectomy for epidural abscess or osteomyelitis, where infected bone is removed and reconstruction is deliberately delayed until infection is controlled. A patient with a sinking skin flap syndrome after craniectomy, where the concave scalp over the defect causes headache and neurologic symptoms that resolve after cranioplasty.
Red-flag warnings after either procedure:
New weakness, slurred speech, or a dilated pupil. A wound that leaks clear fluid (possible cerebrospinal fluid leak). Fever with wound redness or drainage. A helmet or protective headgear that no longer fits after swelling changes. Sudden severe headache with vomiting. Any change in consciousness.
Misconceptions worth correcting
A common misconception is that craniectomy is a bigger, more heroic version of craniotomy. In reality, it is a different trade: it accepts a skull defect and a second operation to buy room for a swollen brain. Another misconception is that the bone flap is always thrown away. It is often preserved, and preservation is part of the surgical plan.
A third misconception is that cranioplasty is purely cosmetic. It restores skull protection and can resolve symptoms of sinking skin flap syndrome, so it is a functional operation. A fourth is that "craniotomy" and "craniectomy" are interchangeable in consent forms or billing; they are distinct procedures with distinct follow-up obligations.
Practical actions and thresholds
For patients and families, the practical steps are concrete:
Ask, before surgery, whether the plan is craniotomy or craniectomy, and whether a craniectomy is a possible intraoperative conversion. If a craniectomy is planned or possible, ask where the bone flap will be stored and when cranioplasty is anticipated. Confirm helmet or head-protection instructions and wound-care instructions in writing. Ask what symptoms should trigger an immediate call or emergency visit (see red flags above). Confirm the follow-up imaging schedule and who is responsible for cranioplasty planning.
For clinicians, the reconcilable thresholds are: intracranial pressure sustained above roughly 20–22 mmHg despite medical therapy as a trigger for decompressive surgery discussion; surgery within 48 hours for malignant hemispheric stroke in selected patients; and individualized cranioplasty timing rather than a fixed universal window. These thresholds come from different bodies of evidence and should be applied to the individual patient, not treated as a single algorithm.
Limits of what can be concluded
The evidence base is strongest for decompressive craniectomy in malignant stroke and weaker, with conflicting trials, in traumatic brain injury. Cranioplasty timing remains genuinely uncertain, and no single number resolves it. This article describes mechanisms and published trial findings; it does not provide patient-specific diagnosis or treatment recommendations. Decisions about skull opening, bone replacement, and reconstruction belong to the treating surgical team with the patient's full clinical picture.